Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

Ludwig Kappos, Giancarlo Comi, Hillel Panitch, Joel Oger, Jack Antel, Paul Conlon, Lawrence Steinman, Alexander Rae-Grant, John Castaldo, Nancy Eckert, Joseph B. Guarnaccia, Pamela Mills, Gary Johnson, Peter A. Calabresi, Carlo Pozzilli, Stefano Bastianello, Elisabetta Giugni, Tatiana Witjas, Patrick Cozzone, Jean PelletierDieter Pöhlau, Horst Przuntek, Volker Hoffmann, Christopher Bever, Eleanor Katz, Michel Clanet, Isabelle Berry, David Brassat, Irene Brunet, Gilles Edan, Pierre Duquette, Ernst Wilhelm Radue, Dagmar Schött, Carmen Lienert, Alice Taksaoui, M. Rodegher, M. Filippi, Alan Evans, Pierre Bourgouin, Alex Zijdenbos, Shawki Salem, Nicholas Ling, David Alleva, Eric Johnson, Amitabh Gaur, Paul Crowe, Xin Jun Liu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds